<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26362772</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1423-0127</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of biomedical science</Title><ISOAbbreviation>J Biomed Sci</ISOAbbreviation></Journal><ArticleTitle>Japanese encephalitis virus replicon-based vaccine expressing enterovirus-71 epitope confers dual protection from lethal challenges.</ArticleTitle><Pagination><StartPage>74</StartPage><MedlinePgn>74</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">74</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12929-015-0181-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To construct safer recombinant flavivirus vaccine, we exploited Japanese encephalitis virus (JEV) replicon-based platform to generate single-round infectious particles (SRIPs) that expressed heterologous neutralizing epitope SP70 derived from enterovirus-71 (EV71). Such pseudo-infectious virus particles, named SRIP-SP70, although are not genuine viable viruses, closely mimic live virus infection to elicit immune responses within one round of viral life cycle.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that, besides gaining of full protection to thwart JEV lethal challenge, female outbred ICR mice, when were immunized with SRIP-SP70 by prime-boost protocol, could not only induce SP70-specific and IgG2a predominant antibodies but also provide their newborns certain degree of protection against EV71 lethal challenge.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results therefore exemplify that this vaccination strategy could indeed confer an immunized host a dual protective immunity against subsequent lethal challenge from JEV or EV71.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yi-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Graduate Institute of Life Sciences, National Defense Medical Center, No. 161 Section 6, Ming Chuan E. Road, Taipei, 114, Taiwan, Republic of China (ROC). wulala902@yahoo.com.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Jia-Teh</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Defense Medical Center, No. 161 Section 6, Ming Chuan E. Road, Taipei, 114, Taiwan, ROC. jiateh.liao@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Li-Chen</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, National Defense Medical Center, No. 161 Section 6, Ming Chuan E. Road, Taipei, 114, Taiwan, ROC. yenlichen@mail.ndmctsgh.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Yung-Kun</ForeName><Initials>YK</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Defense Medical Center, No. 161 Section 6, Ming Chuan E. Road, Taipei, 114, Taiwan, ROC. cqbbbb@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yi-Ling</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, No. 128 Section 2, Academia Road Nankang, Taipei, 115, Taiwan, ROC. yll@ibms.sinica.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Ching-Len</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, National Defense Medical Center, No. 161 Section 6, Ming Chuan E. Road, Taipei, 114, Taiwan, ROC. chinglen@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, No. 35, Keyan Road, Zhunan, Miaoli County, 35053, Taiwan, ROC. chinglen@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Biomed Sci</MedlineTA><NlmUniqueID>9421567</NlmUniqueID><ISSNLinking>1021-7770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004664" MajorTopicYN="N">Encephalitis Virus, Japanese</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015967" MajorTopicYN="N">Gene Expression Regulation, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012093" MajorTopicYN="N">Replicon</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>9</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26362772</ArticleId><ArticleId IdType="pmc">PMC4566489</ArticleId><ArticleId IdType="doi">10.1186/s12929-015-0181-8</ArticleId><ArticleId IdType="pii">10.1186/s12929-015-0181-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kallerup RS, Foged C. Subunit vaccine delivery. New York: Springer-Verlag; 2015. Classification of vaccines; pp. 15&#x2013;29.</Citation></Reference><Reference><Citation>Ulmer JB, Mason PW, Geall A, Mandl CW. RNA-based vaccines. Vaccine. 2012;30(30):4414. doi: 10.1016/j.vaccine.2012.04.060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2012.04.060</ArticleId><ArticleId IdType="pubmed">22546329</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumiyoshi H, Mori C, Fuke I, Morita K, Kuhara S, Kondou J, et al. Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology. 1987;161(2):497. doi: 10.1016/0042-6822(87)90144-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(87)90144-9</ArticleId><ArticleId IdType="pubmed">3686827</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenbach BD, Thiel HJ, Rice CM. Flaviviridae: the viruses and their replication. 5. Philadelphia, Pa: Lippincott-Raven; 2007.</Citation></Reference><Reference><Citation>Lin YL, Chen LK, Liao CL, Yeh CT, Ma SH, Chen JL, et al. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol. 1998;72(1):191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC109364</ArticleId><ArticleId IdType="pubmed">9420215</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Liu S, Yang P, Wang C, Du Y, Yu W, et al. Replicon-based Japanese encephalitis virus vaccines elicit immune response in mice. J Virol Methods. 2012;179(1):217. doi: 10.1016/j.jviromet.2011.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2011.11.002</ArticleId><ArticleId IdType="pubmed">22108431</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii K, Goto A, Kawakami K, Kariwa H, Takashima I. Construction and application of chimeric virus-like particles of tick-borne encephalitis virus and mosquito-borne Japanese encephalitis virus. J Gen Virol. 2008;89(Pt 1):200. doi: 10.1099/vir.0.82824-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82824-0</ArticleId><ArticleId IdType="pubmed">18089744</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki R, Ishikawa T, Konishi E, Matsuda M, Watashi K, Aizaki H, et al. Production of single-round infectious chimeric flaviviruses with DNA-based Japanese encephalitis virus replicon. J Gen Virol. 2014;95(Pt 1):60. doi: 10.1099/vir.0.058008-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.058008-0</ArticleId><ArticleId IdType="pubmed">24096319</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka A, Suzuki R, Konishi E. Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays. Vaccine. 2014;32(34):4289. doi: 10.1016/j.vaccine.2014.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2014.06.017</ArticleId><ArticleId IdType="pubmed">24950360</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang DC, Liu WJ, Anraku I, Clark DC, Pollitt CC, Suhrbier A, et al. Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus. Nat Biotechnol. 2008;26(5):571. doi: 10.1038/nbt1400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt1400</ArticleId><ArticleId IdType="pubmed">18425125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, Lim WL, et al. Fatal enterovirus 71 encephalomyelitis. J Pediatr. 1998;133(6):795. doi: 10.1016/S0022-3476(98)70155-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(98)70155-6</ArticleId><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagana M, Preux PM, Dumas M. Japanese encephalitis revisited. J Neurol Sci. 2007;262(1&#x2013;2):165. doi: 10.1016/j.jns.2007.06.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.06.041</ArticleId><ArticleId IdType="pubmed">17643451</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT, Poh CL. Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res. 2007;125(1):61. doi: 10.1016/j.virusres.2006.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2006.12.005</ArticleId><ArticleId IdType="pubmed">17222936</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo DG, Alonso S, Chow VT, Poh CL. Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide. Microbes Infect. 2007;9(11):1299. doi: 10.1016/j.micinf.2007.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2007.06.002</ArticleId><ArticleId IdType="pubmed">17890123</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang JJ, Liao CL, Liao JT, Lee YL, Lin YL. A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability. Vaccine. 2009;27(21):2746. doi: 10.1016/j.vaccine.2009.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.03.007</ArticleId><ArticleId IdType="pubmed">19366580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78(15):7916. doi: 10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Yen LC, Lin YL, Sung HH, Liao JT, Tsao CH, Su CM, et al. Neurovirulent flavivirus can be attenuated in mice by incorporation of neuron-specific microRNA recognition elements into viral genome. Vaccine. 2013;31(49):5915. doi: 10.1016/j.vaccine.2011.09.102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.09.102</ArticleId><ArticleId IdType="pubmed">22008823</ArticleId></ArticleIdList></Reference><Reference><Citation>Melian EB, Hinzman E, Nagasaki T, Firth AE, Wills NM, Nouwens AS, et al. NS1&#x2019; of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. J Virol. 2010;84(3):1641. doi: 10.1128/JVI.01979-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01979-09</ArticleId><ArticleId IdType="pmc">PMC2812330</ArticleId><ArticleId IdType="pubmed">19906906</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine. 2001;20(5&#x2013;6):895. doi: 10.1016/S0264-410X(01)00385-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(01)00385-1</ArticleId><ArticleId IdType="pubmed">11738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Esser C, Radbruch A. Immunoglobulin class switching: molecular and cellular analysis. Annu Rev Immunol. 1990;8:717. doi: 10.1146/annurev.iy.08.040190.003441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.iy.08.040190.003441</ArticleId><ArticleId IdType="pubmed">2188677</ArticleId></ArticleIdList></Reference><Reference><Citation>Street NE, Mosmann TR. Functional diversity of T lymphocytes due to secretion of different cytokine patterns. FASEB J. 1991;5(2):171.</Citation><ArticleIdList><ArticleId IdType="pubmed">1825981</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CC, Chou AH, Lien SP, Lin HY, Liu SJ, Chang JY, et al. Identification and characterization of a cross-neutralization epitope of Enterovirus 71. Vaccine. 2011;29(26):4362. doi: 10.1016/j.vaccine.2011.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.04.010</ArticleId><ArticleId IdType="pubmed">21501643</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Hsiung CA, Lu CY, Lin TY, Huang FY, Lai YH, et al. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res. 2006;60(4):466. doi: 10.1203/01.pdr.0000238247.86041.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/01.pdr.0000238247.86041.19</ArticleId><ArticleId IdType="pmc">PMC7086547</ArticleId><ArticleId IdType="pubmed">16940249</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>